ASTH — APOLLO MED HLDGS INC COM NEW

Ownership history in EverSource Wealth Advisors, LLC  ·  10 quarters on record

This page tracks every 13F SEC filing in which EverSource Wealth Advisors, LLC reported a position in APOLLO MED HLDGS INC COM NEW (ASTH). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 7 -4 -36.4% 0.00% $198 $28.35
2025 Q1 REDUCED 11 -177 -94.1% 0.00% $341 $31.01
2024 Q3 UNCHANGED 188 — 0% 0.00% $11K $57.94
2024 Q2 UNCHANGED 188 — 0% 0.00% $10K $40.56
6 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    ASTH price (monthly, adj. close)

Other funds also holding ASTH

As of 2025 Q4 — sorted by position size

325 CAPITAL LLC 3Y 15.99% 1492 Capital Management LLC 3Y 7Y 1.59% QSV Equity Investors LLC 1.09% SteelPeak Wealth, LLC 3Y 0.47% Insight Wealth Strategies, LLC 3Y 7Y 0.4% HUSSMAN STRATEGIC ADVISORS, INC. 3Y 7Y 0.38% Shay Capital LLC 3Y 0.31% Capstone Capital Management Ltd 0.28% NorthCrest Asset Manangement, LLC 3Y 0.28% ROYCE & ASSOCIATES LP 3Y 7Y 0.09%
← Back to EverSource Wealth Advisors, LLC Holdings